Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 4
2005 5
2006 4
2007 11
2008 12
2009 11
2010 21
2011 21
2012 20
2013 14
2014 14
2015 12
2016 11
2017 12
2018 8
2019 9
2020 4
2021 6
2022 2
2023 3
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM; Children's Oncology Group. Yu AL, et al. Among authors: reynolds cp. N Engl J Med. 2010 Sep 30;363(14):1324-34. doi: 10.1056/NEJMoa0911123. N Engl J Med. 2010. PMID: 20879881 Free PMC article. Clinical Trial.
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
DuBois SG, Moreno L, Anderson J, Asgharzadeh S, Bagatell R, Beck-Popovic M, Belle J, Berlanga P, Bird NJ, Chesler L, Durbin A, Eggert A, Eilers M, Federico SM, Fischer M, Gatz SA, George RE, George S, Goldsmith KC, Gray J, Heczey A, Irwin MS, Knox L, Lode HN, Ludwinski D, Macy ME, Majzner RG, Maris JM, Modak S, Molenaar JJ, Morgenstern DA, Mossé YP, Owens C, Reynolds CP, Rossig C, Schleiermacher G, Scott L, Sondel PM, Speleman F, van Noesel M, Westermann F, Wienke J, Wolpaw AJ, Park JR, Pearson ADJ. DuBois SG, et al. Among authors: reynolds cp. Pediatr Blood Cancer. 2025 Jun 12:e31831. doi: 10.1002/pbc.31831. Online ahead of print. Pediatr Blood Cancer. 2025. PMID: 40509548 Review.
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study.
Berko ER, Naranjo A, Daniels AA, McNulty SN, Krytska K, Druley T, Zelley K, Koneru B, Chen L, Polkosnik G, Irwin MS, Bagatell R, Maris JM, Reynolds CP, DuBois SG, Park JR, Mossé YP. Berko ER, et al. Among authors: reynolds cp. J Clin Oncol. 2025 May 10;43(14):1673-1684. doi: 10.1200/JCO-24-02407. Epub 2025 Mar 4. J Clin Oncol. 2025. PMID: 40036726 Free PMC article. Clinical Trial.
Coumarin-Based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors.
Jonnalagadda SK, Duan L, Dow LF, Boligala GP, Kosmacek E, McCoy K, Oberley-Deegan R, Chhonker YS, Murry DJ, Reynolds CP, Maurer BJ, Penning TM, Trippier PC. Jonnalagadda SK, et al. Among authors: reynolds cp. ChemMedChem. 2024 Nov 4;19(21):e202400081. doi: 10.1002/cmdc.202400081. Epub 2024 Sep 16. ChemMedChem. 2024. PMID: 38976686
Retinoid therapy of high-risk neuroblastoma.
Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ. Reynolds CP, et al. Cancer Lett. 2003 Jul 18;197(1-2):185-92. doi: 10.1016/s0304-3835(03)00108-3. Cancer Lett. 2003. PMID: 12880980 Review.
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance.
Çoku J, Booth DM, Skoda J, Pedrotty MC, Vogel J, Liu K, Vu A, Carpenter EL, Ye JC, Chen MA, Dunbar P, Scadden E, Yun TD, Nakamaru-Ogiso E, Area-Gomez E, Li Y, Goldsmith KC, Reynolds CP, Hajnoczky G, Hogarty MD. Çoku J, et al. Among authors: reynolds cp. EMBO J. 2022 Apr 19;41(8):e108272. doi: 10.15252/embj.2021108272. Epub 2022 Feb 25. EMBO J. 2022. PMID: 35211994 Free PMC article.
186 results